Table 2.
Association between MICAL-L2 expression and clinicopathologic characteristics (logistic regression analysis)
| Characteristics | Total(N) | Odds Ratio (OR) | P value |
|---|---|---|---|
| T stage (T3&T4 vs. T1&T2) | 453 | 1.191 (0.748–1.904) | 0.462 |
| N stage (N1&N2 vs. N0) | 454 | 1.267 (0.872–1.845) | 0.215 |
| M stage (M1 vs. M0) | 397 | 0.856 (0.499–1.463) | 0.570 |
| Age (> 65 vs. <=65) | 454 | 1.244 (0.856–1.810) | 0.253 |
| Gender (Female vs. Male) | 454 | 1.112 (0.769–1.609) | 0.573 |
| Pathologic stage (Stage III&Stage IV vs. Stage I&Stage II) | 443 | 1.375 (0.944–2.008) | 0.098 |
| Lymphatic invasion (YES vs. NO) | 411 | 1.522 (1.024–2.268) | 0.038 |
| Perineural invasion (YES vs. NO) | 179 | 1.150 (0.585–2.255) | 0.684 |
| BMI (> = 25 vs. < 25) | 232 | 0.714 (0.412–1.232) | 0.226 |
| Primary therapy outcome (PD&SD&PR vs. CR) | 235 | 2.045 (1.032–4.181) | 0.044 |
| Colon polyps present (YES vs. NO) | 225 | 1.073 (0.617–1.860) | 0.803 |